Metraipolis › archive › dc_cb79ee113c01

Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis — Europe PMC PMID:36852153

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36852153
DOI
10.1002/jgh3.12856
License (as archived)
solo-consultazione
Archived
2026-10-07T21:54:23.631Z
SHA-256 of the archived text
1a57ca584871d0d5d4746d59fd0a0ef85d824732a0ef65752ed197748a925d05
Stable URL of this page
https://metraipolis.com/documento/dc_cb79ee113c01

How to cite

Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis — Europe PMC PMID:36852153 — Europe PMC (en), https://europepmc.org/article/MED/36852153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb79ee113c01 (Metraipolis archive dc_cb79ee113c01, sha256 1a57ca584871d0d5d4746d59fd0a0ef85d824732a0ef65752ed197748a925d05)
BibTeX
@misc{dccb79ee113c01,
  title = {Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis — Europe PMC PMID:36852153},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36852153},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb79ee113c01; sha256 1a57ca584871d0d5d4746d59fd0a0ef85d824732a0ef65752ed197748a925d05},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36852153. Agents can read the archived copy with the MCP tool read_document.